RBC Capital holds Boston Scientific stock Outperform rating
In a recent update, RBC Capital analysts have maintained their Outperform rating on Boston Scientific (NYSE:BSX) shares, with ...
RBC Capital Reaffirms Their Buy Rating on Boston Scientific (BSX)
In a report released yesterday, Shagun Singh Chadha from RBC Capital reiterated a Buy rating on Boston Scientific (BSX – Research Report), with ...
TD Cowen maintains Boston Scientific buy rating, $110 target
TD Cowen reiterated a Buy rating for Boston Scientific (NYSE:BSX) stock, maintaining a price target of $110.00. The stock, currently trading at $98.78, has shown remarkable momentum, reaching new ...